Komori
Kawaguchi Chemical Industry (4361) · RiskWorsened

Sluggish operations at existing customers in China and elsewhere

First written in FY2017-Q1. 10 of 23 entries say "Worsened", first in FY2019-Q2. Latest entry: FY2025-H1.

23entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018-Q1 – FY2018-Q3WorsenedFY2019-Q2 – FY2020-Q2RestatedFY2024-Q12017: 320172018: 220182019: 120192020: 420202021: 320212022: 420222023: 420232024: 120242025: 12025
Same theme, other companies
Impact on performance from stagnation in overseas markets, including South Korea and ASEANA theme 42 companies write about · 44 as a headwind · 0 as a tailwind

Kawaguchi Chemical Industry moved to the "Worse" side of this theme in 2019, the same year as the typical company in this theme.

The whole theme swung hardest in 2019: 15 of 34 companies on the "Worse" side.

11 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 42 companies compared. The sentences above are computed from all 42.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1WorsenedAnnual report

    「The market for general-purpose products in Southeast Asia remained sluggish, and sales declined as demand failed to recover. Sales of products for medical rubber applications recovered, but overall sales were below the same period of the previous year.」

    Overseas sales declined due to weak market conditions and a lack of recovery in demand for general-purpose products in Southeast Asia.
  2. FY2024-Q1RestatedAnnual report

    「Sales of general-purpose products and products for medical applications, mainly to China, remained sluggish, but the company was able to sell specialty products in new fields, and overseas sales exceeded the same period of the previous year.」

    While weak sales of general-purpose products for China and products for medical applications continued, overseas sales exceeded the same period of the previous year due to sales of specialty products in new fields.
  3. FY2023-Q3WorsenedAnnual report

    「Sales volumes, mainly to the automotive industry, declined due to the severe impact of China's economic stagnation. However, sales increased, helped by the weaker yen and by the return of demand and sales for certain products.」

    Sales volume for the overseas automotive industry declined due to the downturn in China's economy, and operating rates among existing customers and in related markets in China and elsewhere remained weak. Meanwhile, revenue increased due to the weaker yen and other factors.
  4. FY2023-Q2RestatedAnnual report

    「Sales volume of rubber chemicals fell below the same period of the previous year due to inventory adjustments by domestic and overseas customers, mainly in the automotive sector, and the downturn in the Chinese market. However, revenue exceeded the same period of the previous year, partly due to the effects of price revisions.」

    Sales volume fell below the same period of the previous year due to inventory adjustments by domestic and overseas customers and the downturn in the Chinese market, but revenue exceeded the same period of the previous year following price revisions.
  5. FY2023-Q1RestatedAnnual report

    「Overseas sales were severely affected by production cuts in China's automotive industry, resulting in lower sales of products used in automotive components.」

    The adverse effects of production cuts in China's automotive industry on customer operating rates and sales continue.
  6. FY2022WorsenedAnnual report

    「In China, the economy slowed as the impact of zero-COVID measures intensified the decline in personal consumption and restrictions on production activity.」

    Among existing customers and in related markets in China, weak consumption and production restrictions resulting from the zero-COVID policy intensified, and the economic slowdown progressed.
  7. FY2022-Q3WorsenedAnnual report

    「Overseas sales decreased as the company was heavily affected by reduced production in the automotive industry, sales of products for automotive parts and tire applications declined, and demand for the medical rubber application products in which the company specializes slowed.」

    Among overseas customers and in related markets, sales and revenue declined as demand for products used in medical rubber applications slowed, in addition to production cuts in the automotive industry.
  8. FY2022-Q2WorsenedAnnual report

    「Overseas sales decreased as the company was heavily affected by reduced production in the automotive industry, sales of key products declined, and demand for the medical rubber application products in which the company specializes slowed.」

    Among overseas customers and in related markets, sales of key products and revenue declined due to production cuts in the automotive industry and slower demand for products used in medical rubber applications.
  9. FY2022-Q1WorsenedAnnual report

    「Meanwhile, the recovery in market conditions and expansion of customer demand in Southeast Asian countries leveled off, resulting in slower demand and lower sales.」

    The recovery in market conditions and expansion of customer demand that had continued in Southeast Asia leveled off, resulting in slower demand and lower sales.
  10. FY2021AdvancedAnnual report

    「The company actively responded to expanding customer demand accompanying the recovery in market conditions in Southeast Asian countries, led by substantially higher sales at its Chinese subsidiary in the Chinese market.」

    Our Chinese subsidiary achieved a substantial increase in sales and responded to expanding customer demand accompanying the recovery in market conditions in Southeast Asia.
  11. FY2021-Q3AdvancedAnnual report

    「Market conditions in Southeast Asian countries clearly recovered, led by a substantial increase in sales by our Chinese subsidiary in the Chinese market, where the economy was showing a marked recovery from the effects of the COVID-19 pandemic.」

    In the Chinese market, our Chinese subsidiary achieved a substantial increase in sales, while market conditions in Southeast Asia also clearly recovered.
  12. FY2021-Q2AdvancedAnnual report

    「Overseas sales increased substantially in the Chinese market, where the economy recovered early from the impact of COVID-19, and the recovery trend in automotive production in Southeast Asian countries became more pronounced.」

    Conditions among overseas customers and in related markets improved due to a substantial increase in sales in the Chinese market and a recovery in vehicle production in Southeast Asia.
  13. FY2021-Q1MitigatedAnnual report

    「Overseas sales exceeded the same period of the previous year, driven by the recovery in automotive production in Southeast Asian countries, including China, where the economy recovered early from the impact of COVID-19.」

    Vehicle production related to existing customers in China and Southeast Asia recovered, and overseas sales exceeded the same period of the previous year.
  14. FY2020-Q3RestatedAnnual report

    「Overseas sales were significantly below the same period of the previous year, as the economies of Southeast Asian countries deteriorated substantially after being heavily affected by the spread of COVID-19, reducing automotive production and sales.」

    Economic deterioration, lower vehicle production and sales, and a significant year-on-year decline in overseas sales continued across Southeast Asia.
  15. FY2020-Q2WorsenedAnnual report

    「Overseas sales were significantly below the same period of the previous year, as the economies of Southeast Asian countries deteriorated substantially after being heavily affected by the spread of COVID-19, reducing automotive production and sales.」

    Vehicle production and sales declined among overseas customers and in related markets, including China and Southeast Asia, and overseas sales fell significantly below the same period of the previous year.
  16. FY2020-Q1WorsenedAnnual report

    「Overseas sales were below the same period of the previous year, reflecting the impact of COVID-19 on production activity in China and automotive production in Southeast Asian countries falling below the same period of the previous year.」

    China's production activity was affected by COVID-19, while vehicle production in Southeast Asia also fell below the same period of the previous year, resulting in lower overseas sales than in the same period of the previous year.
  17. FY2019WorsenedAnnual report

    「Production in East Asia, including China, fell below the previous year.」

    For existing customers and related markets in China and elsewhere, production remained below the previous year even for the full year.
  18. FY2019-Q2WorsenedAnnual report

    「In overseas markets, sales of some products increased as a result of developing customers for new products and actively responding to changes in customer demand and requests, but sales fell below the same period of the previous year because of lower operating rates at some customers.」

    Lower operating rates among some overseas customers were cited as a factor behind actual overseas sales falling below the same period of the previous year.
  19. FY2018-Q3RestatedAnnual report

    「Overseas sales exceeded the same period of the previous year as existing customers in countries including China continued to recover. We actively pursued sales expansion tailored to market demand for each product, and also secured new orders.」

    Existing customers, including those in China, continued to recover, and overseas sales exceeded the same period of the previous year due to sales expansion efforts and new orders.
  20. FY2018-Q1RestatedAnnual report

    「Overseas sales exceeded the same period of the previous year as existing customers, including those in China, continued to recover. Although the yen remained strong during the period, we actively pursued sales expansion tailored to market demand for each product.」

    Existing customers, including those in China, continue to show signs of recovery.
  21. FY2017-Q3MitigatedAnnual report

    「For exports, we actively pursued sales expansion as existing customers, including those in China, showed signs of recovery and the yen remained weak against other currencies, although」

    Existing customers, including those in China, are continuing to recover, with the improvement from their previously weak operating rates continuing.
  22. FY2017-Q2MitigatedAnnual report

    「Export sales volume and revenue both exceeded the same period of the previous year, as existing customers, including those in China, showed signs of recovery and the yen remained weak against other currencies, while we actively pursued sales expansion among existing customers.」

    Existing customers, including those in China, showed signs of recovery, with both sales volume and revenue exceeding the same period of the previous year.
  23. FY2017-Q1First statedAnnual report

    「Sales declined as operating rates among existing customers, including those in China, remained weak and competition with companies from other countries intensified further.」

    Weak operating rates among existing customers in China and elsewhere were listed independently for the first time as a factor behind the decline in export sales.
Moved together

"Overseas Expansion Focused on China and Southeast Asia" moved the same way as this thread, in the same document, in 12 of its 23 moves.

12109966★123456
  1. ★This thread
  2. 1Overseas Expansion Focused on China and Southeast Asia12×
  3. 2Slowdown and Weakness in the Chinese and Asian Economies10×
  4. 3Impact on Business Performance from Changes in Demand, Prices, Competition, and the Economic Environment9×
  5. 4Domestic and overseas rubber chemicals sales exceeded the same period of the previous year9×
  6. 5Weakness in auto-related industries due to sluggish domestic automobile production6×
  7. 6Revenue Growth from Winning Orders for Pharmaceutical Intermediates and Functional Chemicals6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Kawaguchi Chemical Industry yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Sluggish operations at existing customers in China and elsewhere | KAWAGUCHI CHEMICAL INDUSTRY CO.,LTD. (4361) | Komori